Mini Review
Published on 16 Jun 2020
Breast Cancer Survivorship, Quality of Life, and Late Toxicities
in Women's Cancer
Frontiers in Oncology
doi 10.3389/fonc.2020.00864
- 33,946 views
- 297 citations
44 articles related to "Late Toxicities"
Articles
Original Research
Published on 11 Jan 2017
Development of Late Toxicities in Patients with Oral Tongue Cancer Treated with Surgical Resection and Adjuvant Radiation Therapy
in Radiation Oncology
Frontiers in Oncology
doi 10.3389/fonc.2016.00272
- 4,081 views
- 8 citations
Review
Published on 20 Sep 2021
Early-Stage Glottic Squamous Cell Carcinoma in the Era of Image-Guided Radiotherapy
in Head and Neck Cancer
Frontiers in Oncology
doi 10.3389/fonc.2021.753908
- 16,224 views
- 11 citations
Original Research
Published on 25 Feb 2021
Contralateral Lower Neck Sparing Radiotherapy in Stage N1 Nasopharyngeal Carcinoma: Long-Term Survival Outcomes and Late Toxicities
in Radiation Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.628919
- 3,556 views
- 7 citations
Original Research
Published on 20 Jan 2023
Long-term outcomes of nasopharyngeal carcinoma treated with helical tomotherapy using simultaneous integrated boost technique: A 10-year result
in Head and Neck Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.1083440
- 2,842 views
- 5 citations
Original Research
Published on 05 Feb 2020
Long-Term Patient-Reported Quality of Life After Stereotactic Body Radiation Therapy for Recurrent, Previously-Irradiated Head and Neck Cancer
in Radiation Oncology
Frontiers in Oncology
doi 10.3389/fonc.2020.00083
- 4,214 views
- 10 citations
Perspective
Published on 25 Feb 2022
Advances in Hodgkin Lymphoma: Including the Patient’s Voice
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.855725
- 5,711 views
- 4 citations
Original Research
Published on 23 Mar 2021
The Acute and Late Toxicities of MRI-Guided External Beam Partial Breast Irradiation Delivered Using a Once-Per-Day Regimen
in Radiation Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.649301
- 4,232 views
- 8 citations
Original Research
Published on 05 Jul 2021
Low-Dose Radiotherapy Versus Moderate-Dose Radiotherapy for the Treatment of Indolent Orbital Adnexal Lymphomas
in Radiation Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.716002
- 3,813 views
- 7 citations
Mini Review
Published on 10 Dec 2019
A Brief Review of Low-Dose Rate (LDR) and High-Dose Rate (HDR) Brachytherapy Boost for High-Risk Prostate
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2019.01378
- 22,878 views
- 32 citations
Original Research
Published on 03 Mar 2023
Chemoradiotherapy in geriatric patients with squamous cell carcinoma of the esophagus: Multi-center analysis on the value of standard treatment in the elderly
in Gastrointestinal Cancers: Gastric and Esophageal Cancers
Frontiers in Oncology
doi 10.3389/fonc.2023.1063670
- 3,930 views
- 11 citations
Clinical Case Study
Published on 24 Feb 2015
Treating Cutaneous T-Cell Lymphoma with Highly Irregular Surfaces with Photon Irradiation Using Rice as Tissue Compensator
in Radiation Oncology
Frontiers in Oncology
doi 10.3389/fonc.2015.00049
- 7,520 views
- 7 citations
Original Research
Published on 14 Jan 2015
Safety and Tolerability of SBRT after High-Dose External Beam Radiation to the Lung
in Radiation Oncology
Frontiers in Oncology
doi 10.3389/fonc.2014.00376
- 6,913 views
- 13 citations
Original Research
Published on 17 Nov 2021
Mixed-Beam Approach for High-Risk Prostate Cancer Carbon-Ion Boost Followed by Photon Intensity-Modulated Radiotherapy: Preliminary Results of Phase II Trial AIRC-IG-14300
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.778729
- 2,984 views
- 3 citations
Original Research
Published on 11 Aug 2017
Reductive Metabolism Influences the Toxicity and Pharmacokinetics of the Hypoxia-Targeted Benzotriazine Di-Oxide Anticancer Agent SN30000 in Mice
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2017.00531
- 5,230 views
- 17 citations
Review
Published on 20 Jan 2022
Evolution of a Paradigm Switch in Diagnosis and Treatment of HPV-Driven Head and Neck Cancer—Striking the Balance Between Toxicity and Cure
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2021.753387
- 9,186 views
- 25 citations